Xenon Pharmaceuticals XENE Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's income tax?
- Xenon Pharmaceuticals (XENE) reported income tax of -$2.57M in Q1 2026.
- How has Xenon Pharmaceuticals's income tax changed year-over-year?
- Xenon Pharmaceuticals's income tax decreased by 702.1% year-over-year, from $427K to -$2.57M.
- What is the long-term trend for Xenon Pharmaceuticals's income tax?
- Over 3 years (2022 to 2025), Xenon Pharmaceuticals's income tax has grown at a 105.0% compound annual growth rate (CAGR), from $118K to $1.02M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.